OMNI BIO PHARMACEUTICAL, INC.: 10-Q filed 2015-02-17
What OMNI BIO PHARMACEUTICAL, INC. reported in its quarterly report filed 2015-02-17 (fiscal Q3 2015): 22 published measures, 57 facts as tagged in accession 0001437749-15-002851.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-02-17
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001437749-15-002851 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All OMNI BIO PHARMACEUTICAL, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,032,711 | USD | |
| At 2014-03-31 | 496,981 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 3,855,437 | USD | |
| At 2014-03-31 | 1,381,239 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | -2,822,727 | USD | |
| At 2014-03-31 | -884,258 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 852,372 | USD | |
| At 2014-03-31 | 271,427 | USD | |
| At 2013-12-31 | 485,104 | USD | |
| At 2013-03-31 | 343,279 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -1,399,001 | USD | 92 |
| 2014-04-01 to 2014-12-31 | -3,222,352 | USD | 275 |
| 2013-10-01 to 2013-12-31 | -755,397 | USD | 92 |
| 2013-04-01 to 2013-12-31 | -2,076,428 | USD | 275 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-12-31 | -1,421,155 | USD | 275 |
| 2013-04-01 to 2013-12-31 | -1,219,573 | USD | 275 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-12-31 | 2,002,100 | USD | 275 |
| 2013-04-01 to 2013-12-31 | 1,361,398 | USD | 275 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-12-31 | 226,628 | USD | 275 |
| 2013-04-01 to 2013-12-31 | 474,073 | USD | 275 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -522,164 | USD | 92 |
| 2014-04-01 to 2014-12-31 | -1,668,999 | USD | 275 |
| 2013-10-01 to 2013-12-31 | -446,498 | USD | 92 |
| 2013-04-01 to 2013-12-31 | -1,615,856 | USD | 275 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 921,889 | USD | |
| At 2014-03-31 | 303,628 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,602,603 | USD | |
| At 2014-03-31 | 96,338 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 8,701 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 522,164 | USD | 92 |
| 2014-04-01 to 2014-12-31 | 1,668,999 | USD | 275 |
| 2013-10-01 to 2013-12-31 | 446,498 | USD | 92 |
| 2013-04-01 to 2013-12-31 | 1,615,856 | USD | 275 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 111,906 | USD | 92 |
| 2014-04-01 to 2014-12-31 | 470,687 | USD | 275 |
| 2013-10-01 to 2013-12-31 | 36,250 | USD | 92 |
| 2013-04-01 to 2013-12-31 | 162,838 | USD | 275 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 40,205,880 | shares | |
| At 2014-03-31 | 38,656,638 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 46,891,012 | USD | |
| At 2014-03-31 | 45,608,679 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 59,810 | USD | |
| At 2014-03-31 | 63,494 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 150,591 | USD | |
| At 2014-03-31 | 87,637 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 410,258 | USD | 92 |
| 2014-04-01 to 2014-12-31 | 1,198,311 | USD | 275 |
| 2013-10-01 to 2013-12-31 | 410,248 | USD | 92 |
| 2013-04-01 to 2013-12-31 | 1,453,018 | USD | 275 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-12-31 | 3,685 | USD | 275 |
| 2013-04-01 to 2013-12-31 | 3,685 | USD | 275 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -876,837 | USD | 92 |
| 2014-04-01 to 2014-12-31 | -1,553,353 | USD | 275 |
| 2013-10-01 to 2013-12-31 | -308,899 | USD | 92 |
| 2013-04-01 to 2013-12-31 | -460,572 | USD | 275 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-12-31 | -8,701 | USD | 275 |
| 2013-04-01 to 2013-12-31 | -29,741 | USD | 275 |
Inspect the source
- Entity
- OMNI BIO PHARMACEUTICAL, INC. / CIK 0001389870
- Captured
- SEC response SHA-256
b9b3aba6d21aa6d13f2cc53a72b3619a8dce8e5c14df68ddd1351a61e50303b7
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001389870.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))